Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Rao

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Experimental & Molecular Medicine|May 9, 2015
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapyFang Wang, Jian-fang Lou, Yan Cao, et al.
Acta Pharmaceutica Sinica. B|June 27, 2022
Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cellsPeilu Song, Fan Zhao, Dahong Li, et al.
Cancer Causes & Control : CCC|October 30, 2013
Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variationTingting Yang, Po-Yin Chang, Sungshim Lani Park, et al.
Gynecologic Oncology|July 2, 2019
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapyEmily N Prendergast, Laura L Holman, Annie Y Liu, et al.
Oncogene|February 3, 2025
Correction: BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Current Neurovascular Research|March 22, 2021
miR-666-3p Mediates the Protective Effects of Mesenchymal Stem Cell-derived Exosomes Against Oxygen-glucose Deprivation and Reoxygenation- induced Cell Injury in Brain Microvascular Endothelial Cells via Mitogen-activated Protein Kinase PathwayLi-Yun Kong, Yan Li, Ding-Yu Rao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Lung cancer chemoprevention with celecoxib in former smokersJenny T Mao, Michael D Roth, Michael C Fishbein, et al.
Oncogene|August 20, 2024
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 30, 2013
A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomyStephen J Freedland, Michael Carducci, Nils Kroeger, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8<sup>+</sup> T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1Wen-Hao Yang, Bao-Yue Huang, Hsing-Yu Rao, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Experimental & Molecular Medicine|May 9, 2015
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapyFang Wang, Jian-fang Lou, Yan Cao, et al.
Acta Pharmaceutica Sinica. B|June 27, 2022
Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cellsPeilu Song, Fan Zhao, Dahong Li, et al.
Cancer Causes & Control : CCC|October 30, 2013
Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variationTingting Yang, Po-Yin Chang, Sungshim Lani Park, et al.
Gynecologic Oncology|July 2, 2019
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapyEmily N Prendergast, Laura L Holman, Annie Y Liu, et al.
Oncogene|February 3, 2025
Correction: BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Current Neurovascular Research|March 22, 2021
miR-666-3p Mediates the Protective Effects of Mesenchymal Stem Cell-derived Exosomes Against Oxygen-glucose Deprivation and Reoxygenation- induced Cell Injury in Brain Microvascular Endothelial Cells via Mitogen-activated Protein Kinase PathwayLi-Yun Kong, Yan Li, Ding-Yu Rao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Lung cancer chemoprevention with celecoxib in former smokersJenny T Mao, Michael D Roth, Michael C Fishbein, et al.
Oncogene|August 20, 2024
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expressionYanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 30, 2013
A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomyStephen J Freedland, Michael Carducci, Nils Kroeger, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8<sup>+</sup> T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1Wen-Hao Yang, Bao-Yue Huang, Hsing-Yu Rao, et al.
Pageof 30